Reevaluating the evidence for blood pressure targets in type 2 diabetes

Diabetes Care

Volumn 41, Issue 6, 2018, Pages 1132-1133

  Lamprea Montealegre, Julio A ^a,b   De Boer, Ian H ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALL CAUSE MORTALITY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; GLYCEMIC CONTROL; HEART FAILURE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK REDUCTION;

EID: 85047496866     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dci17-0063     Document Type: Article

References (20)

1. de Boer IH, Bangalore S, Benetos A, et al. Diabetes and hypertension: A position statement by the American Diabetes Association. Diabetes Care 2017;40:1273-1284
2. American Diabetes Association. 9. Cardiovascular disease and risk management: Standards of Medical Care in Diabetesd2018. Diabetes Care 2018;41(Suppl. 1):S86-S104
3. Whelton PK, Karey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J AmColl Cardiol. 7 November 2017 [Epub ahead of print]. DOI: 10.1016/j.jacc.2017.11.006
4. SPRINT ResearchGroup, Wright JT Jr, Williamson JD, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015;373:2103-2116
5. Cushman WC, Evans GW, Byington RP, et al.; ACCORD Study Group. Effects of intensive bloodpressure control in type 2 diabetes mellitus. N Engl J Med 2010;362:1575-1585
6. MargolisKL, O'Connor PJ, Morgan TM, et al. Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: The ACCORD randomized trial. Diabetes Care 2014;37: 1721-1728
7. Mi MY, Mukamal KJ. Comment on Buckley et al. Intensive versus standard blood pressure control in SPRINT-eligible participants of ACCORDBP. Diabetes Care 2017;40:1733-1738 (Letter).
8. Mi MY, Mukamal KJ. Comment on Buckley et al. Intensive versus standard blood pressure control in SPRINT-eligible participants of ACCORDBP. Diabetes Care 2018;41:e84-e85
9. Buckley LF, Dixon DL, Wohlford GF IV, Wijesinghe DS, Baker WL, Van Tassell BW. Intensive versus standard blood pressure control in SPRINT-eligible participants of ACCORD-BP. Diabetes Care 2017;40:1733-1738
10. Johnson KC, Whelton PK, Cushman WC, et al.; SPRINT Research Group. Blood pressure measurement in SPRINT (Systolic Blood Pressure Intervention Trial). Hypertension. 12 March 2018 [Epub ahead of print]. DOI: 10.1161/ HYPERTENSIONAHA.117.10479
11. Wan EYF, Yu EYT, Chin WY, et al. Effect of achieved systolic blood pressure on cardiovascular outcomes in patients with type 2 diabetes: A population-based retrospective cohort study. Diabetes Care 2018;41:1134-1141
12. Perkovic V, Rodgers A. Redefining bloodpressure targets-SPRINT starts the marathon. N Engl J Med 2015;373:2175-2178
13. Brouwer TF, Vehmeijer JT, Kalkman DN, et al. Intensive blood pressure lowering in patients with and patientswithout type 2 diabetes: A pooled analysis from two randomized trials. Diabetes Care 2018;41:1142-1148
14. Boudina S, Abel ED. Diabetic cardiomyopathy, causes and effects. Rev EndocrMetab Disord 2010;11:31-39
15. Chen NX, Moe SM. Arterial calcification in diabetes. Curr Diab Rep 2003;3:28-32
16. Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes 2008;26: 77-82
17. Siscovick DS, Sotoodehnia N, Rea TD, Raghunathan TE, Jouven X, Lemaitre RN. Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community. Rev EndocrMetab Disord 2010;11: 53-59
18. McCoy RG, Van Houten HK, Ziegenfuss JY, Shah ND, Wermers RA, Smith SA. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care 2012;35:1897-1901
19. Peron EP, Ogbonna KC, Donohoe KL. Antidiabetic medications and polypharmacy. Clin Geriatr Med 2015;31:17-27, vii
20. Rao Kondapally Seshasai S, Kaptoge S, Thompson A, et al.; Emerging Risk Factors Collaboration. Diabetes mellitus, fasting glucose, and risk of causespecific death. N Engl J Med 2011;364:829-841